Amanote Research
Register
Sign In
Aberrant Gene Promoter Methylation Marking Disease Progression in Multiple Myeloma
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2404205
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
April 6, 2006
Authors
C-S Chim
R Liang
M-H Leung
S-F Yip
Y-L Kwong
Publisher
Springer Nature
Related search
Aberrant DNA Methylation in P1 Promoter Region of Tp53 Gene in Acute Leukemia
Journal of Leukemia
Targeting Aberrant DNA Methylation in Mesenchymal Stromal Cells as a Treatment for Myeloma Bone Disease
Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
American Journal of Pathology
Forensic Medicine
Pathology
Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer’s Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Aberrant Promoter Methylation Profiles and Association With Survival in Patients With Hepatocellular Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Retraction Note To: Aberrant Promoter Methylation of RASSF1A Gene May Be Correlated With Colorectal Carcinogenesis: A Meta-Analysis
Molecular Biology Reports
Medicine
Genetics
Molecular Biology
Aberrant Methylation of the Adenomatous Polyposis Coli (APC) Gene Promoter Is Associated With the Inflammatory Breast Cancer Phenotype
British Journal of Cancer
Cancer Research
Oncology
Aberrant GRK6 Promoter Methylation Is Associated With Poor Prognosis in Hypopharyngeal Squamous Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology